What Tinlo is and what it is used for?
Tinlo contains the active substance Erlotinib. Tinlo is a medicine used to treat cancer by preventing the activity of a protein called epidermal growth factor receptor (EGFR). This protein is known to be involved in the growth and spread of cancer cells.
Tinlo is indicated for adults. This medicine can be prescribed to you if you have non-small cell lung cancer at an advanced stage. It can be prescribed as initial therapy or as therapy if your disease remains largely unchanged after initial chemotherapy, provided your cancer cells have specific EGFR mutations. It can also be prescribed if previous chemotherapy has not helped to stop your disease.
This medicine can also be prescribed to you in combination with another treatment called gemcitabine if you have cancer of the pancreas at a metastatic stage.
Before you take Tinlo
Do not take Tinlo
Warnings and precautions:
Talk to your doctor or pharmacist before taking Tinlo.
Take special care with Tinlo:
Children and adolescents
Tinlo has not been studied in patients under the age of 18 years. The treatment with this medicine is not recommended for children and adolescents.
Other medicines and Tinlo
Tell your doctor or pharmacist if you are taking, have recently taken any other medicines or might take any other medicines.
Pregnancy and breast-feeding
Avoid pregnancy while being treated with Tinlo. If you could become pregnant, use adequate contraception during treatment, and for at least 2 weeks after taking the last tablet.
If you become pregnant while you are being treated with Tinlo, immediately inform your doctor who will decide if the treatment should be continued.
Do not breast-feed if you are being treated with Tinlo, and for at least 2 weeks after taking the last tablet.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Tinlo has not been studied for its possible effects on the ability to drive and use machines but it is very unlikely that your treatment will affect this ability.
Tinlo contains a sugar called lactose monohydrate
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Tinlo.
How to take Tinlo?
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The tablet should be taken at least one hour before or two hours after the ingestion of food. Don’t take Tinlo with food.
The usual dose is one tablet of Erlotinib 150 mg each day if you have non-small cell lung cancer.
The usual dose is one tablet of Erlotinib 100 mg each day if you have metastatic pancreatic cancer. Tinlo is given in combination with gemcitabine treatment.
Your doctor may adjust your dose in 50 mg steps.
If you take more Tinlo than you should
Contact your doctor or pharmacist immediately. You may have increased side effects and your doctor may interrupt your treatment.
If you forget to take Tinlo
If you miss one or more doses of Tinlo, contact your doctor or pharmacist as soon as possible. Do not take a double dose to make up for a forgotten dose.
If you stop taking Tinlo
It is important to keep taking Tinlo every day, as long as your doctor prescribes it for you. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
How to store Tinlo?
Keep out of the reach of children.
Store below 30°C. Protect from light and moisture.
Do not use this medicine after the expiry date which is stated on the label and carton.
The medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Further information
What Tinlo contains?
The active substance is Erlotinib (as hydrochloride). Each film-coated tablet contains Erlotinib (as hydrochloride) 150 mg.
The other ingredients are: Lactose Monohydrate, Microcrystalline Cellulose, Sodium Starch Glycolate, Magnesium Stearate, Sodium Lauryl Sulfate.
What Tinlo looks like and contents of the pack?
Tinlo are white colored, round, biconvex film coated tablets.
Tinlo is available in the boxes of 3 blisters, each one containing 10 tablets.
Manufactured by:
Actero Middle East Pharmaceutical Company, Karaj, Iran
Keep out of the reach of children.
Store below 30°C. Protect from light and moisture.
Do not use this medicine after the expiry date which is stated on the label and carton.
The medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.